Table 2 Demographic characteristics of the ERAS and control groups
Characteristic | ERAS Group(n = 59) | Control Group(n = 36) | P value |
|---|---|---|---|
Age (years, mean ± SD) | 41.71 ± 11.72 | 40.56 ± 12.14 | 0.646 |
Sex, male(n(%)) | 48(81.36%) | 32(88.89%) | 0.329 |
BMI (kg/m2, mean ± SD) | 26.75 ± 3.33 | 26.56 ± 3.11 | 0.783 |
ASA classification(n(%)) | Â | Â | 0.703 |
 Class I | 27(45.76%) | 15(41.67%) |  |
 Class II | 29(49.15%) | 19(52.78%) |  |
 Class III | 3(5.09%) | 2(5.55%) |  |
NYHA classification(n(%)) | Â | Â | 0.927 |
 Class I | 49(83.05%) | 30(83.33%) |  |
 Class II | 10(16.95%) | 6(16.67%) |  |
Mallampati classification(n(%)) | Â | Â | 0.394 |
 Class I | 7(11.86%) | 8(22.22%) |  |
 Class II | 28(47.46%) | 14(38.89%) |  |
 Class III | 21(35.59%) | 14(38.89%) |  |
 Class IV | 3(5.09%) | 0(0%) |  |
OSAHS severity(n(%)) | Â | Â | 0.557 |
 Mild | 10(16.95%) | 9(25.00%) |  |
 Moderate | 16(27.12%) | 8(22.22%) |  |
 Severe | 33(55.93%) | 19(52.78%) |  |
Complications(n(%)) | 15(25.42%) | 10(27.78%) | 0.800 |
 Hypertension | 15(25.42%) | 9(25.00%) | 0.963 |
 Diabetes | 2(3.39%) | 2(5.56%) | 0.610 |